{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,2]],"date-time":"2026-07-02T22:24:16Z","timestamp":1783031056105,"version":"3.54.6"},"reference-count":41,"publisher":"Springer Science and Business Media LLC","issue":"2","license":[{"start":{"date-parts":[[2025,7,3]],"date-time":"2025-07-03T00:00:00Z","timestamp":1751500800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2025,7,3]],"date-time":"2025-07-03T00:00:00Z","timestamp":1751500800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"funder":[{"DOI":"10.13039\/100000026","name":"National Institute on Drug Abuse","doi-asserted-by":"publisher","award":["K08DA058052"],"award-info":[{"award-number":["K08DA058052"]}],"id":[{"id":"10.13039\/100000026","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000026","name":"National Institute on Drug Abuse","doi-asserted-by":"publisher","award":["R01 DA058367"],"award-info":[{"award-number":["R01 DA058367"]}],"id":[{"id":"10.13039\/100000026","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000060","name":"National Institute of Allergy and Infectious Diseases","doi-asserted-by":"publisher","award":["5P30AI042853"],"award-info":[{"award-number":["5P30AI042853"]}],"id":[{"id":"10.13039\/100000060","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["J GEN INTERN MED"],"published-print":{"date-parts":[[2026,1]]},"DOI":"10.1007\/s11606-025-09700-6","type":"journal-article","created":{"date-parts":[[2025,7,3]],"date-time":"2025-07-03T12:43:44Z","timestamp":1751546624000},"page":"516-520","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":1,"title":["Aligning Efforts to Boost Medications for Opioid Use Disorder and Pre-Exposure Prophylaxis for HIV"],"prefix":"10.1007","volume":"41","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-4178-0720","authenticated-orcid":false,"given":"Alyssa S.","family":"Tilhou","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sabrina A.","family":"Assoumou","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jeffrey H.","family":"Samet","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2025,7,3]]},"reference":[{"issue":"25","key":"9700_CR1","doi-asserted-by":"publisher","first-page":"567","DOI":"10.15585\/mmwr.mm7325a1","volume":"73","author":"D Dowell","year":"2024","unstructured":"Dowell D, Brown S, Gyawali S, et al. Treatment for Opioid Use Disorder: Population Estimates\u2014United States, 2022. Morbidity and Mortality Weekly Report. 2024;73(25):567-574.","journal-title":"Morbidity and Mortality Weekly Report."},{"key":"9700_CR2","unstructured":"Data Brief 491. Drug Overdose Deaths in the United States, 2002\u20132022. Centers for Disease Control and Prevention Accessed February 9, 2025. https:\/\/www.cdc.gov\/nchs\/data\/databriefs\/db491-tables.pdf"},{"key":"9700_CR3","unstructured":"HIV Surveillance Supplemental Report: Estimated HIV Incidence and Prevalence in the United States, 2018\u20132022. Centers for Disease Control and Prevention Accessed February 9, 2025. https:\/\/stacks.cdc.gov\/view\/cdc\/156513"},{"key":"9700_CR4","unstructured":"Massachusetts Department of Public Health Bureau of Infectious Disease and Laboratory Sciences. Massachusetts HIV Epidemiologic Profile Statewide Report \u2013 Data as of 1\/1\/2023, Page 9.; 2023. Accessed May 8, 2024. https:\/\/www.mass.gov\/doc\/statewide-report-data-as-of-112023\/download"},{"key":"9700_CR5","unstructured":"HIV Surveillance Report, 2021; Vol. 34. Centers for Disease Control and Prevention; 2023. Accessed April 24, 2024. https:\/\/www.cdc.gov\/hiv\/library\/reports\/hiv-surveillance\/vol-34\/index.html"},{"key":"9700_CR6","doi-asserted-by":"publisher","first-page":"103786","DOI":"10.1016\/j.drugpo.2022.103786","volume":"110","author":"N Krawczyk","year":"2022","unstructured":"Krawczyk N, Rivera BD, Jent V, Keyes KM, Jones CM, Cerd\u00e1 M. Has the treatment gap for opioid use disorder narrowed in the US?: A yearly assessment from 2010 to 2019\u201d. International Journal of Drug Policy. 2022;110:103786.","journal-title":"International Journal of Drug Policy."},{"issue":"2","key":"9700_CR7","doi-asserted-by":"publisher","first-page":"52","DOI":"10.1007\/s11904-024-00697-x","volume":"21","author":"SE Rutstein","year":"2024","unstructured":"Rutstein SE, Muessig KE. Leveling Up PrEP: Implementation Strategies at System and Structural Levels to Expand PrEP Use in the United States. Curr HIV\/AIDS Rep. 2024;21(2):52-61. https:\/\/doi.org\/10.1007\/s11904-024-00697-x","journal-title":"Curr HIV\/AIDS Rep."},{"key":"9700_CR8","unstructured":"Estimated HIV Incidence and Prevalence. Centers for Disease Control and Prevention; 2025. Accessed March 18, 2025. https:\/\/www.cdc.gov\/hiv-data\/nhss\/estimated-hiv-incidence-and-prevalence.html#cdc_survey_profile_key_findings-key-findings"},{"issue":"4","key":"9700_CR9","doi-asserted-by":"publisher","first-page":"994","DOI":"10.1007\/s10461-016-1672-7","volume":"21","author":"SR Friedman","year":"2017","unstructured":"Friedman SR, Mateu-Gelabert P, Ruggles KV, et al. Sexual Risk and Transmission Behaviors, Partnerships and Settings Among Young Adult Nonmedical Opioid Users in New York City. AIDS Behav. 2017;21(4):994-1003. https:\/\/doi.org\/10.1007\/s10461-016-1672-7","journal-title":"AIDS Behav."},{"key":"9700_CR10","doi-asserted-by":"publisher","first-page":"53","DOI":"10.1016\/j.drugalcdep.2014.07.026","volume":"144","author":"ES Herrmann","year":"2014","unstructured":"Herrmann ES, Hand DJ, Johnson MW, Badger GJ, Heil SH. Examining delay discounting of condom-protected sex among opioid-dependent women and non-drug-using control women. Drug and Alcohol Dependence. 2014;144:53-60.","journal-title":"Drug and alcohol dependence."},{"key":"9700_CR11","doi-asserted-by":"publisher","first-page":"108477","DOI":"10.1016\/j.jsat.2021.108477","volume":"130","author":"A Ludwig","year":"2021","unstructured":"Ludwig A, Monico LB, Gryczynski J, et al. Drug and sexual HIV-risk behaviors among adolescents and young adults with opioid use disorder. Journal of Substance Abuse Treatment. 2021;130:108477.","journal-title":"Journal of substance abuse treatment."},{"key":"9700_CR12","doi-asserted-by":"publisher","first-page":"105779","DOI":"10.1016\/j.ypmed.2019.105779","volume":"126","author":"KA Brookmeyer","year":"2019","unstructured":"Brookmeyer KA, Haderxhanaj LT, Hogben M, Leichliter J. Sexual risk behaviors and STDs among persons who inject drugs: a national study. Preventive Medicine. 2019;126:105779.","journal-title":"Preventive medicine."},{"issue":"1","key":"9700_CR13","doi-asserted-by":"publisher","first-page":"17","DOI":"10.1016\/j.amepre.2022.07.011","volume":"64","author":"MS Ellis","year":"2023","unstructured":"Ellis MS, Kasper ZA, Takenaka B, Buttram ME, Shacham E. Associations of transactional sex and sexually transmitted infections among treatment-seeking individuals with opioid use disorder. American Journal of Preventive Medicine. 2023;64(1):17-25.","journal-title":"American Journal of Preventive Medicine."},{"issue":"9","key":"9700_CR14","doi-asserted-by":"publisher","first-page":"979","DOI":"10.1001\/jamapsychiatry.2021.0976","volume":"78","author":"T Santo","year":"2021","unstructured":"Santo T, Clark B, Hickman M, et al. Association of opioid agonist treatment with all-cause mortality and specific causes of death among people with opioid dependence: a systematic review and meta-analysis. JAMA Psychiatry. 2021;78(9):979-993.","journal-title":"JAMA psychiatry."},{"issue":"9883","key":"9700_CR15","doi-asserted-by":"publisher","first-page":"2083","DOI":"10.1016\/S0140-6736(13)61127-7","volume":"381","author":"K Choopanya","year":"2013","unstructured":"Choopanya K, Martin M, Suntharasamai P, et al. Bangkok Tenofovir Study Group Antiretroviral prophylaxis for HIV infection in injecting drug users in Bangkok, Thailand (the Bangkok Tenofovir Study): a randomised, double-blind, placebo-controlled phase 3 trial. Lancet. 2013;381(9883):2083-2090.","journal-title":"Lancet."},{"key":"#cr-split#-9700_CR16.1","unstructured":"US Public Health Service. Preexposure Prophylaxis for the Prevention of HIV Infection in the United States - 2021 Update. Centers for Disease Control and Prevention"},{"key":"#cr-split#-9700_CR16.2","unstructured":"2021. Accessed June 5, 2024. https:\/\/www.cdc.gov\/hiv\/pdf\/risk\/prep\/cdc-hiv-prep-guidelines-2021.pdf"},{"key":"9700_CR17","doi-asserted-by":"crossref","unstructured":"Arwady MA, Delphin-Rittmon M, Volkow ND. Major Gaps in the Cascade of Care for Opioid Use Disorder: Implications for Clinical Practice. JAMA. 2024;332(9):701-702","DOI":"10.1001\/jama.2024.11977"},{"key":"9700_CR18","doi-asserted-by":"publisher","first-page":"108506","DOI":"10.1016\/j.jsat.2021.108506","volume":"132","author":"L Beck","year":"2022","unstructured":"Beck L, Parlier-Ahmad AB, Martin CE. Pre-exposure prophylaxis (PrEP) indication and uptake among people receiving buprenorphine for the treatment of opioid use disorder. Journal of Substance Abuse Treatment. 2022;132:108506.","journal-title":"Journal of substance abuse treatment."},{"key":"9700_CR19","doi-asserted-by":"crossref","unstructured":"Walsh SL, El-Bassel N, Jackson RD, et al. The HEALing (Helping to End Addiction Long-term SM) Communities Study: Protocol for a cluster randomized trial at the community level to reduce opioid overdose deaths through implementation of an integrated set of evidence-based practices. Drug and Alcohol Dependence. 2020;217:108335.","DOI":"10.1016\/j.drugalcdep.2020.108335"},{"issue":"9","key":"9700_CR20","doi-asserted-by":"publisher","first-page":"844","DOI":"10.1001\/jama.2019.1343","volume":"321","author":"AS Fauci","year":"2019","unstructured":"Fauci AS, Redfield RR, Sigounas G, Weahkee MD, Giroir BP. Ending the HIV epidemic: a plan for the United States. Jama. 2019;321(9):844-845.","journal-title":"JAMA"},{"issue":"4","key":"9700_CR21","doi-asserted-by":"publisher","first-page":"268","DOI":"10.7326\/M16-2149","volume":"166","author":"PT Korthuis","year":"2017","unstructured":"Korthuis PT, McCarty D, Weimer M, et al. Primary care\u2013based models for the treatment of opioid use disorder: A scoping review. Annals of internal medicine. 2017;166(4):268-278.","journal-title":"Annals of Internal Medicine."},{"issue":"2","key":"9700_CR22","doi-asserted-by":"publisher","first-page":"S79","DOI":"10.1016\/S0376-8716(03)00061-9","volume":"70","author":"TP Bridge","year":"2003","unstructured":"Bridge TP, Fudala PJ, Herbert S, Leiderman DB. Safety and health policy considerations related to the use of buprenorphine\/naloxone as an office-based treatment for opiate dependence. Drug and alcohol dependence. 2003;70(2):S79-S85.","journal-title":"Drug and alcohol dependence."},{"issue":"1","key":"9700_CR23","doi-asserted-by":"publisher","first-page":"43","DOI":"10.1097\/JAN.0000000000000160","volume":"28","author":"KS Fornili","year":"2017","unstructured":"Fornili KS, Fogger SA. Nurse practitioner prescriptive authority for buprenorphine: From DATA 2000 to CARA 2016. Journal of addictions nursing. 2017;28(1):43-48.","journal-title":"Journal of Addictions Nursing."},{"key":"9700_CR24","unstructured":"Substance Abuse and Mental Health Services Administration. FAQs: Provision of methadone and buprenorphine for the treatment of Opioid Use Disorder in the COVID-19 emergency. Published online April 21, 2020. Accessed October 15, 2021. https:\/\/www.samhsa.gov\/sites\/default\/files\/faqs-for-oud-prescribing-and-dispensing.pdf"},{"issue":"6","key":"9700_CR25","doi-asserted-by":"publisher","first-page":"984","DOI":"10.1377\/hlthaff.2019.01622","volume":"39","author":"M Olfson","year":"2020","unstructured":"Olfson M, Zhang V, Schoenbaum M, King M. Buprenorphine Treatment By Primary Care Providers, Psychiatrists, Addiction Specialists, And Others: Trends in buprenorphine treatment by prescriber specialty-primary care providers, psychiatrists, and addiction medicine specialists. Health Affairs. 2020;39(6):984-992. https:\/\/doi.org\/10.1377\/hlthaff.2019.01622","journal-title":"Health Affairs."},{"key":"9700_CR26","doi-asserted-by":"publisher","unstructured":"Larochelle MR, Jones CM, Zhang K. Change in opioid and buprenorphine prescribers and prescriptions by specialty, 2016\u20132021. Drug and Alcohol Dependence. 2023;248:109933. https:\/\/doi.org\/10.1016\/j.drugalcdep.2023.109933","DOI":"10.1016\/j.drugalcdep.2023.109933"},{"key":"9700_CR27","doi-asserted-by":"crossref","unstructured":"Carter E, Schatz D, Isaacs N, et al. Application of an Opioid Use Disorder Cascade of Care in a Large Public Health System. The American Journal of Drug and Alcohol Abuse. 2024;50(2):181-190 https:\/\/www.ncbi.nlm.nih.gov\/pmc\/articles\/PMC10614983\/","DOI":"10.1080\/00952990.2024.2302500"},{"key":"9700_CR28","doi-asserted-by":"crossref","unstructured":"Tilhou A, Gasman S, Wang J, et al. Assessing inequities in buprenorphine treatment across the care cascade. Drug and Alcohol Dependence. 2025;270:112636.","DOI":"10.1016\/j.drugalcdep.2025.112636"},{"key":"9700_CR29","doi-asserted-by":"crossref","unstructured":"Solomon KT, O\u2019Connor J, Gibbons JB, et al. Association between hospital adoption of an emergency department treatment pathway for opioid use disorder and patient initiation of buprenorphine after discharge. JAMA Health Forum. 2023;4:e230245-e230245. https:\/\/jamanetwork.com\/journals\/jama-health-forum\/article-abstract\/2802874","DOI":"10.1001\/jamahealthforum.2023.0245"},{"issue":"5","key":"9700_CR30","doi-asserted-by":"publisher","first-page":"731","DOI":"10.1097\/QAD.0000000000001385","volume":"31","author":"AS Nunn","year":"2017","unstructured":"Nunn AS, Brinkley-Rubinstein L, Oldenburg CE, et al. Defining the HIV pre-exposure prophylaxis care continuum. Aids. 2017;31(5):731-734.","journal-title":"Aids."},{"key":"9700_CR31","doi-asserted-by":"crossref","unstructured":"Bozinoff N, Grennell E, Soobiah C, et al. Facilitators of and barriers to buprenorphine initiation in the emergency department: a scoping review. The Lancet Regional Health\u2013Americas. 2024;38. https:\/\/www.thelancet.com\/journals\/lanam\/article\/PIIS2667-193X(24)00226-6\/fulltext","DOI":"10.1016\/j.lana.2024.100899"},{"issue":"4","key":"9700_CR32","doi-asserted-by":"publisher","first-page":"441","DOI":"10.1080\/08897077.2019.1675118","volume":"40","author":"JL Taylor","year":"2019","unstructured":"Taylor JL, Walley AY, Bazzi AR. Stuck in the Window with You: HIV Exposure Prophylaxis in the Highest Risk People who Inject Drugs. Substance Abuse. 2019;40(4):441-443. https:\/\/doi.org\/10.1080\/08897077.2019.1675118","journal-title":"Substance Abuse."},{"issue":"9","key":"9700_CR33","doi-asserted-by":"publisher","first-page":"e2334540","DOI":"10.1001\/jamanetworkopen.2023.34540","volume":"6","author":"LC Chambers","year":"2023","unstructured":"Chambers LC, Hallowell BD, Zullo AR, et al. Buprenorphine dose and time to discontinuation among patients with opioid use disorder in the era of fentanyl. JAMA Network Open. 2023;6(9):e2334540-e2334540.","journal-title":"JAMA Network Open."},{"key":"9700_CR34","doi-asserted-by":"crossref","unstructured":"Morgan JR, Walley AY, Murphy SM, et al. Characterizing initiation, use, and discontinuation of extended-release buprenorphine in a nationally representative United States commercially insured cohort. Drug and Alcohol Dependence. 2021(225):108764.","DOI":"10.1016\/j.drugalcdep.2021.108764"},{"key":"9700_CR35","doi-asserted-by":"publisher","first-page":"41","DOI":"10.1016\/j.jsat.2018.08.009","volume":"94","author":"A Lo","year":"2018","unstructured":"Lo A, Kerr T, Hayashi K, et al. Factors associated with methadone maintenance therapy discontinuation among people who inject drugs. Journal of Substance Abuse Treatment. 2018;94:41-46.","journal-title":"Journal of substance abuse treatment."},{"issue":"1","key":"9700_CR36","doi-asserted-by":"publisher","first-page":"3","DOI":"10.1097\/XEB.0000000000000303","volume":"20","author":"H Khalil","year":"2022","unstructured":"Khalil H, Lakhani A. Using systems thinking methodologies to address health care complexities and evidence implementation. JBI Evidence Implementation. 2022;20(1):3-9.","journal-title":"JBI Evidence Implementation."},{"key":"9700_CR37","doi-asserted-by":"publisher","first-page":"S286","DOI":"10.1097\/MLR.0000000000001144","volume":"57","author":"AM Kilbourne","year":"2019","unstructured":"Kilbourne AM, Goodrich DE, Miake-Lye I, Braganza MZ, Bowersox NW. Quality enhancement research initiative implementation roadmap: toward sustainability of evidence-based practices in a learning health system. Medical Care. 2019;57:S286-S293.","journal-title":"Medical care."},{"issue":"01","key":"9700_CR38","doi-asserted-by":"publisher","first-page":"100","DOI":"10.1055\/s-0041-1741482","volume":"13","author":"P Jonnalagadda","year":"2022","unstructured":"Jonnalagadda P, Swoboda C, Singh P, et al. Developing Dashboards to Address Children\u2019s Health Disparities in Ohio. Appl Clin Inform. 2022;13(01):100-112. https:\/\/doi.org\/10.1055\/s-0041-1741482","journal-title":"Appl Clin Inform."},{"key":"9700_CR39","doi-asserted-by":"publisher","first-page":"108331","DOI":"10.1016\/j.drugalcdep.2020.108331","volume":"217","author":"E Wu","year":"2020","unstructured":"Wu E, Villani J, Davis A, et al. Community dashboards to support data-informed decision-making in the HEALing communities study. Drug and Alcohol Dependence. 2020;217:108331.","journal-title":"Drug and alcohol dependence."},{"issue":"6","key":"9700_CR40","doi-asserted-by":"publisher","first-page":"889","DOI":"10.2105\/AJPH.2022.306847","volume":"112","author":"LE Thorpe","year":"2022","unstructured":"Thorpe LE, Gourevitch MN. Data Dashboards for Advancing Health and Equity: Proving Their Promise? Am J Public Health. 2022;112(6):889-892. https:\/\/doi.org\/10.2105\/AJPH.2022.306847","journal-title":"Am J Public Health."}],"container-title":["Journal of General Internal Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s11606-025-09700-6.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s11606-025-09700-6","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s11606-025-09700-6.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,7,2]],"date-time":"2026-07-02T22:05:33Z","timestamp":1783029933000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s11606-025-09700-6"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,7,3]]},"references-count":41,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2026,1]]}},"alternative-id":["9700"],"URL":"https:\/\/doi.org\/10.1007\/s11606-025-09700-6","relation":{},"ISSN":["0884-8734","1525-1497"],"issn-type":[{"value":"0884-8734","type":"print"},{"value":"1525-1497","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,7,3]]},"assertion":[{"value":"14 April 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"17 June 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"3 July 2025","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors declare that they do not have a conflict of interest.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of Interest"}},{"value":"This content has been made available to all.","name":"free","label":"Free to read"}]}}